141 pr conjugated mouse anti human ccr6 (fluidigm)
fluidigm is a verified supplier 
fluidigm manufactures this product 
92
Structured Review
fluidigm
141 pr conjugated mouse anti human ccr6
141 Pr Conjugated Mouse Anti Human Ccr6, supplied by fluidigm, used in various techniques. Bioz Stars score: 92/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ccr6+141+pr+g034e3/Anti-Human+CD196%2FCCR6+(G034E3)-141Pr/pmc12583509-46-0-6
Average 92 stars, based on 9 article reviews
141 Pr Conjugated Mouse Anti Human Ccr6, supplied by fluidigm, used in various techniques. Bioz Stars score: 92/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ccr6+141+pr+g034e3/Anti-Human+CD196%2FCCR6+(G034E3)-141Pr/pmc12583509-46-0-6
Average 92 stars, based on 9 article reviews
141 pr conjugated mouse anti human ccr6 - by Bioz Stars,
2026-09
92/100 stars
Images
Related Articles
Blocking Assay:Article Title: NKG2A blockade potentiates CD8 T-cell immunity induced by cancer vaccines Article Snippet: CCR6 – 141 Pr (G034E3) , Purification:Article Title: NKG2A blockade potentiates CD8 T-cell immunity induced by cancer vaccines Article Snippet: CCR6 – 141 Pr (G034E3) , Virus:Article Title: NKG2A blockade potentiates CD8 T-cell immunity induced by cancer vaccines Article Snippet: CCR6 – 141 Pr (G034E3) , Recombinant:Article Title: NKG2A blockade potentiates CD8 T-cell immunity induced by cancer vaccines Article Snippet: CCR6 – 141 Pr (G034E3) , Staining:Article Title: NKG2A blockade potentiates CD8 T-cell immunity induced by cancer vaccines Article Snippet: CCR6 – 141 Pr (G034E3) , Transfection:Article Title: NKG2A blockade potentiates CD8 T-cell immunity induced by cancer vaccines Article Snippet: CCR6 – 141 Pr (G034E3) , Cell Stimulation:Article Title: NKG2A blockade potentiates CD8 T-cell immunity induced by cancer vaccines Article Snippet: CCR6 – 141 Pr (G034E3) , Adjuvant:Article Title: NKG2A blockade potentiates CD8 T-cell immunity induced by cancer vaccines Article Snippet: CCR6 – 141 Pr (G034E3) , Mutagenesis:Article Title: NKG2A blockade potentiates CD8 T-cell immunity induced by cancer vaccines Article Snippet: CCR6 – 141 Pr (G034E3) , Transgenic Assay:Article Title: NKG2A blockade potentiates CD8 T-cell immunity induced by cancer vaccines Article Snippet: CCR6 – 141 Pr (G034E3) , Marker:Article Title: NKG2A blockade potentiates CD8 T-cell immunity induced by cancer vaccines Article Snippet: CCR6 – 141 Pr (G034E3) , Sequencing:Article Title: NKG2A blockade potentiates CD8 T-cell immunity induced by cancer vaccines Article Snippet: CCR6 – 141 Pr (G034E3) , Expressing:Article Title: NKG2A blockade potentiates CD8 T-cell immunity induced by cancer vaccines Article Snippet: CCR6 – 141 Pr (G034E3) , Plasmid Preparation:Article Title: NKG2A blockade potentiates CD8 T-cell immunity induced by cancer vaccines Article Snippet: CCR6 – 141 Pr (G034E3) , Software:Article Title: NKG2A blockade potentiates CD8 T-cell immunity induced by cancer vaccines Article Snippet: CCR6 – 141 Pr (G034E3) , CRISPR:Article Title: NKG2A blockade potentiates CD8 T-cell immunity induced by cancer vaccines Article Snippet: CCR6 – 141 Pr (G034E3) , |
